|
|
|
| Trends in mortality of liver cancer in Wenzhou City from 2014 to 2022 |
| YE Zhenmiao, FAN Lihui, ZHENG Yuhang, ZHANG Mohan, JIANG Xuexia, LUO Yongyuan, XIE Yimin, JIN Xi, LI Huijun
|
| Department of Non-communicable Diseases Control and Prevention, Wenzhou Center for Disease Control and Prevention, Wenzhou, Zhejiang 325000, China |
|
|
|
|
Abstract Objective To analyze the trends in mortality of liver cancer in Wenzhou City, Zhejiang Province from 2014 to 2022, so as to provide the evidence for improving liver cancer control measures. Methods Data of liver cancer mortality in Wenzhou City from 2014 to 2022 were collected from Wenzhou Chronic Disease Monitoring Information System. The crude mortality were estimated and standardized by the national population census data in China in 2010, and the trends in mortality of liver cancer were analyzed with average annual percent change (AAPC). Results There were 22 033 liver cancer deaths from 2014 to 2022, accounting for 18.08% of malignant tumor deaths and ranking the second in malignant tumor deaths. The crude mortality of liver cancer was 30.00/105 and the standardized mortality was 24.32/105, both showing decreasing trends (AAPC=-2.812% and -5.742%, both P<0.05). The standardized mortality of liver cancer were higher in men than in women (36.66/105 vs. 11.21/105, P<0.05), both showing decreasing trends (AAPC=-5.702% and -5.521%, both P<0.05). The crude mortality of liver cancer appeared a tendency towards a rise with age (P<0.05), with the highest crude mortality in the group aged 80 to 84 years, reaching 145.12/105. The crude mortality of liver cancer showed a tendency towards a decline among residents aged under 15 years, 15 to 44 years, 45 to 64 years and 65 years and above (AAPC=-20.311%, -6.569%, -7.408% and -3.177%, all P<0.05). Conclusions The mortality of liver cancer showed a tendency towards a decline in Wenzhou City from 2014 to 2022. Men and the elderly were high-risk groups for liver cancer deaths, and prevention should be strengthened based on risk factors.
|
|
Received: 02 February 2024
Revised: 16 March 2024
Published: 17 May 2024
|
|
|
|
|
|
[1] ZENG H M,CHEN W Q,ZHENG R S,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):555-567.
[2] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3] 曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2021,13(3):63-69.
[4] 杨帆,曹毛毛,李贺,等.1990—2019年中国人群肝癌流行病学趋势分析及预测[J].中华消化外科杂志,2022,21(1):106-113.
[5] 李江峰,邵永强,郑艳容.温州市2010—2011年恶性肿瘤发病水平和聚集性分析[J].中国预防医学杂志,2014,15(6):593-596.
[6] 邵永强,李江峰,樊丽辉,等.温州市居民恶性肿瘤死亡分布特征分析[J].中国农村卫生事业管理,2014,34(2):164-166.
[7] ZHENG R S,ZHANG S W,ZENG H M,et al.Cancer incidence and mortality in China,2016[J].J Nat Cancer Cent,2022,2(1):1-9.
[8] 冯程程,余秋丽,梁雪萌,等.2015—2019年云南省居民肝癌死亡趋势及寿命损失分析[J].中华疾病控制杂志,2023,27(1):11-16.
[9] 应焱燕,王永,陈洁平,等.2002—2021年宁波市肝癌死亡趋势分析[J].预防医学,2022,34(12):1218-1223.
[10] 柴文杰,王良友,乔冬菊,等.2010—2016年台州市居民肝癌发病和死亡趋势分析[J].预防医学,2019,31(9):933-935.
[11] 王鹏举.1990—2019年我国肝癌发病与死亡趋势及预测研究[D].兰州:兰州大学,2021.
[12] 孙惠昕,张茂祥,王婉莹,等.2013—2017年黑龙江省肿瘤登记地区肝癌发病与死亡分析及变化趋势[J].中国癌症防治杂志,2021,13(2):149-154.
[13] 郑荣寿,张思维,孙可欣,等.2016年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2023,45(3):212-220.
[14] WANG Y Q,LI H Z,GONG W W,et al.Cancer incidence and mortality in Zhejiang Province,Southeast China,2016:a population-based study[J].Chin Med J(Engl),2021,134(16):1959-1966.
[15] 程向东,杜灵彬.2022浙江省肿瘤登记年报[M].北京:清华大学出版社,2023.
[16] 赫捷,陈万青,沈洪兵,等.中国人群肝癌筛查指南(2022,北京)[J].临床肝胆病杂志,2022,38(8):1739-1758.
[17] 贾祥鹤,付振涛,姜帆,等.山东省居民2013—2018年肝癌发病和死亡趋势分析[J].中国公共卫生,2023,39(10):1315-1320.
[18] 谢博,李兰香,胡艳玲.1990—2019年中国乙型肝炎疾病负担分析及趋势预测[J].数理医药学杂志,2023,36(3):166-176.
[19] 郑纲,张沛绮,陈茜,等.温州市鹿城区居民慢性病相关行为危险因素现况调查[J].中国农村卫生事业管理,2018,38(11):1447-1449.
[20] 杨桂丽,陈镭,张晓红,等.温州市居民健康素养与吸烟行为调查[J].预防医学,2018,30(3):253-256.
[21] 史雯,周洋,袁辰,等.2018年浙江省健康人群乙型肝炎血清流行病学调查分析[J].疾病监测,2020,35(10):904-908.
[22] ZHENG R S,QU C F,ZHANG S W,et al.Liver cancer incidence and mortality in China:temporal trends and projections to 2030[J].Chin J Cancer Res,2018,30(6):571-579. |
|
|
|
